Subsequently, we identified GEP100 as a guanine-nucleotide exchange factor that activates Arf6 in the acquisition of invasive and metastatic traits of breast cancer cells upon activation of the epidermal growth factor (EGF)receptor pathway (145). Here, EGF is linked to breast carcinoma.